Filing Details

Accession Number:
0001179110-17-007578
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-19 13:47:56
Reporting Period:
2017-05-17
Filing Date:
2017-05-19
Accepted Time:
2017-05-19 13:47:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1109354 Bruker Corp BRKR Laboratory Analytical Instruments (3826) 043110160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1133649 H Frank Laukien C/O Bruker Corporation
40 Manning Road
Billerica MA 01821
Ceo, President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-17 38,000 $26.11 37,750,851 No 4 P Direct
Common Stock Acquisiton 2017-05-18 35,000 $26.33 37,785,851 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,846,499 Indirect By Former Spouse
Common Stock 1,042 Indirect By Spouse
Common Stock 344,007 Indirect By Son
Common Stock 343,527 Indirect By Daughter
Common Stock 201,702 Indirect As UTMA custodian for son
Common Stock 22,820 Indirect As UTMA custodian for son
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.89 to $26.25, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.81 to $26.44, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) of this Form 4.
  3. The reporting person disclaims beneficial ownership of 1,042 shares held by the reporting person's spouse, 7,400 shares held by the reporting person's adult son and 6,920 shares held by the reporting person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.